Feedback / Questions
WVE-120102 - Wave Life Sciences, Takeda
WVE-120102: Regulatory approval for Huntington's disease in FY2025/FY2026
(Takeda)
-
Feb 5, 2021 -
Q3 FY2020 Results
Regulatory
•
Huntington's Disease
https://www.takeda.com/48fe84/siteassets/system/investors/quarterly-announcements/fy2020/qr2020_q3_p01_en.pdf
Feb 5, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious